Pharmacy Market BUZZ

Market News, Products, Services, and Trends

SCA Pharma CEO Boyer to Take Part in HSCA Panel Discussion


SCA Pharma CEO Boyer to Take Part in HSCA Panel Discussion


SCA Pharma’s CEO Milton Boyer will be a featured speaker for a panel discussion on 503B Compounding at the 2020 Healthcare Supply Chain Association (HSCA) National Pharmacy Forum on Feb. 4, 2020. 


The Forum, taking place Feb. 3-5, in Scottsdale, AZ, brings together pharmaceutical supply chain professionals, industry representatives and others to discuss the latest trends in the industry.


SCA Pharma, a privately held FDA 503B outsourcing facility, is a recognized leader in the field of sterile compounding. Licensed in all 50 states, SCA Pharma offers a robust catalog of products, as well as outstanding quality and customer service. 


For more information, contact marketing@scapharma.com.

 






Today's Posts
Subscribe

This post is related to:

Admixture Compounding Services (503B Outsourcing Facilities)